All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
ceronapril
Known as:
1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)proline
, ceranapril
Â
Â
National Institutes of Health
Topic mentions per year
Topic mentions per year
1990-1999
0
2
4
6
1990
1999
Related topics
Related topics
4 relations
Broader (4)
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Organophosphorus Compounds
Proline
Related mentions per year
Related mentions per year
1936-2018
1940
1960
1980
2000
2020
ceronapril
Antihypertensive Agents
Proline
Angiotensin-Converting Enzyme Inhibitors
Organophosphorus Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The lipophilic properties of angiotensin I-converting enzyme inhibitors do not influence their diffusion through cultured endothelium.
Walter Raasch
,
Andreas Dendorfer
,
B. Ball
,
Paulina Maria Dominiak
Japanese journal of pharmacology
1999
The background for these investigations was the discovery that formation of angiotensin II by the renin angiotensin system can…Â
(More)
Is this relevant?
1997
1997
The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Brenda Costall
,
Randy Naylor
British journal of pharmacology
1997
1. The ability of 5-HT2 and 5-HT4 receptor antagonists to modify the disinhibitory profile of diazepam and other agents was…Â
(More)
Is this relevant?
1996
1996
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patients.
Neal R. Cutler
,
John J. Sramek
,
+4 authors
J. J. Brennan
The Annals of pharmacotherapy
1996
OBJECTIVE To assess the effect of the angiotensin-converting enzyme inhibitor ceronapril on cerebral blood flow (CBF) in patients…Â
(More)
Is this relevant?
1993
1993
Angiotensin(1-7) in the spontaneously hypertensive rat.
Katsuhiko Kohara
,
K. Bridget Brosnihan
,
Carlos Maria Ferrario
Peptides
1993
We profiled the concentrations of angiotensin I (Ang I), angiotensin II (Ang II), and angiotensin(1-7) [Ang(1-7)] by the…Â
(More)
Is this relevant?
1993
1993
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease.
A. Sudilovsky
,
Neal R. Cutler
,
+5 authors
Stefania Repetti
Alzheimer disease and associated disorders
1993
This pilot clinical trial was a 15-week, double-blind, controlled, three-way crossover study evaluating cognitive effects of…Â
(More)
Is this relevant?
1993
1993
Ceranapril and cerebral blood flow autoregulation.
M Torup
,
Glusiec Waldemar
,
Olaf B. Paulson
Journal of hypertension
1993
OBJECTIVE To investigate the effect of the new angiotensin converting enzyme inhibitor ceranapril (1 mg/kg) on the cerebral blood…Â
(More)
Is this relevant?
1992
1992
Angiotensin-converting enzyme inhibition, angiotensin, and cognition.
J. M. Barnes
,
Nakita Barnes
,
+5 authors
T. J. Williams
Journal of cardiovascular pharmacology
1992
In these studies, we have investigated possible cognition-enhancing effects of angiotensin-converting enzyme (ACE) inhibition…Â
(More)
Is this relevant?
1992
1992
A neuroleptic-like effect of ceronapril on latent inhibition.
I. M. Weiner
,
A. D. Smith
,
J Nick P Rawlins
,
Joram Feldon
Neuroscience
1992
Three experiments that used a latent inhibition procedure to investigate the effects of ceronapril on attentional processes in…Â
(More)
Is this relevant?
1992
1992
Relative Lipophilicities and Structural-Pharmacological Considerations of Various Angiotensin-Converting Enzyme (ACE) Inhibitors
Sunanda A. Ranadive
,
Andrew X. Chen
,
Abu T M Serajuddin
Pharmaceutical Research
1992
Lipophilicities of seven structurally diverse angiotensin-converting enzyme (ACE) inhibitors, viz., captopril, zofenoprilat…Â
(More)
Is this relevant?
1992
1992
Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats.
Larry A. Grupp
Pharmacology, biochemistry, and behavior
1992
While it is known that randomly bred normotensive Wistar stock and hypertensive rats alter their alcohol consumption when…Â
(More)
Is this relevant?